Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
|Articles|April 17, 2015

Sigma-Aldrich Opens Cell Culture Technical Center in Singapore

The new center will primarily support SAFC’s biopharmaceutical development and manufacturing clients in Asia.

 

Sigma Aldrich announced on Apr. 17, 2015 that the company is opening a new technical center to service its biopharmaceutical clients looking to develop their research and production capacities.

"The development and manufacturing of biologics, whether innovative new products or generic versions of existing drugs (biosimilars), continues to be an attractive area of growth as our customers continue pushing the boundaries of science and advancing their ability to treat and cure disease," said Jason Apter, vice-president and managing director, Asia Pacific for Sigma-Aldrich, in a press release.

The center will specifically provide cell culture media and optimization service, as well as preclinical media manufacturing for customized production of non-cGMP batches of materials.

Sigma-Aldrich also said it also has plans in the works to open its own cGMP distribution center in Tuas, Singapore, and this facility is expected to open at the end of 2015.

Source: Sigma-Aldrich


Related to this article

The BioPharm Brief: Long-Term Survival Data for a PD-L1/4-1BB Bispecific, Celldex Exits Atopic Dermatitis, and a Fc-Fusion GLP-1 Goes Global
Leads Biolabs details survival data and 2027 ADC combination plans for its PD-L1/4-1BB bispecific opamtistomig, Celldex Therapeutics ends its atopic dermatitis program for anti-KIT antibody barzolvolimab after a phase 2 miss, and Innogen licenses its Fc-fusion GLP-1 receptor agonist efsubaglutide alfa to Arcera Life Sciences for international markets.